Sinil Kim
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment
Papers in
-
- Renal cell carcinoma treatment 13
- Pharmacology 12
- Fungal Biology and Applications 12
- Co-authors
- Brian I. Rini (9 shared papers)Brad Rosbrook (11 shared papers)Paul W. Bycott (12 shared papers)Katherine Liau (7 shared papers)Jamal Tarazi (10 shared papers)Peter C. Trask (6 shared papers)Robert John Motzer (6 shared papers)Connie Chen (3 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (7 papers)The Lancet Oncology (5 papers)Gynecologic Oncology (4 papers)Journal of Clinical Oncology (4 papers)The Journal of Microbiology (3 papers)
- Partner nations
- United StatesSouth KoreaFrance
In The Last Decade
Sinil Kim
78 papers receiving 7.9k citations
Sinil Kim's Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 2.3k
- Pulmonary and Respiratory Medicine 3.3k
- Oncology 1.9k
- Molecular Biology 3.5k
- Endocrinology, Diabetes and Metabolism 519
Countries citing papers authored by Sinil Kim
This map shows the geographic impact of Sinil Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sinil Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sinil Kim more than expected).
Fields of papers citing papers by Sinil Kim
This network shows the impact of papers produced by Sinil Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sinil Kim. The network helps show where Sinil Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside Sinil Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial Hit paper breakdown → | 2011 | 1544 |
| 2 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours Hit paper breakdown → | 2020 | 761 |
| 3 | Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors Hit paper breakdown → | 2016 | 747 |
| 4 | Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial Hit paper breakdown → | 2013 | 610 |
| 5 | Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study Hit paper breakdown → | 2008 | 540 |
| 6 | 2007 | 376 | |
| 7 | Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial Hit paper breakdown → | 2013 | 348 |
| 8 | 2011 | 348 | |
| 9 | 2009 | 288 | |
| 10 | 2008 | 210 | |
| 11 | 2013 | 195 | |
| 12 | 1983 | 167 | |
| 13 | 2011 | 161 | |
| 14 | 2009 | 154 | |
| 15 | 2013 | 121 | |
| 16 | 2011 | 96 | |
| 17 | 2014 | 95 | |
| 18 | 2011 | 91 | |
| 19 | 1994 | 90 | |
| 20 | 1993 | 89 |
About Sinil Kim
Sinil Kim is a scholar working on Pulmonary and Respiratory Medicine, Pharmacology, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 80 papers that have together received 8.2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (13 papers), Fungal Biology and Applications (12 papers), Mycorrhizal Fungi and Plant Interactions (7 papers), Fungal and yeast genetics research (7 papers), Intraperitoneal and Appendiceal Malignancies (6 papers), Nanoparticle-Based Drug Delivery (5 papers), CRISPR and Genetic Engineering (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). The work is most often cited by research in Cancer Research (2.3k citations), Pulmonary and Respiratory Medicine (3.3k citations), Oncology (1.9k citations), Molecular Biology (3.5k citations) and Endocrinology, Diabetes and Metabolism (519 citations). Sinil Kim has collaborated with scholars based in United States, South Korea and France. Frequent co-authors include Brian I. Rini, Brad Rosbrook, Paul W. Bycott, Katherine Liau, Jamal Tarazi, Peter C. Trask, Robert John Motzer, Connie Chen, Olivier Rixe and Thomas E. Hutson. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, The Lancet Oncology, Gynecologic Oncology, Journal of Clinical Oncology and The Journal of Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.